Introduction
Systemic infections with multiresistant enterococci are a major problem in hospitals worldwide. From relative triviality, enterococci have become a leading cause of nosocomial infection, currently ranking the top 3 of microorganisms causing nosocomial bacteremia in the United States [1] . The rise in incidence has, in part, been attributed to changes in medical care, e.g. the growth in the numbers of immunocompromised and critically ill patients, the increased use of intravascular devices, more prolonged hospital stays, and the widespread use of antibiotics to which the enterococci are resistant [2, 3] . Particularly the ability to acquire resistance genes by E. faecium facilitated the rise in incidence of enterococcal infection and led to an increase in the relative importance of E. faecium as a pathogen. Currently, β-lactam and vancomycin-resistance has almost completely penetrated the clinical population of E. faecium, with 90 and 80 % of all E.
faecium from nosocomial infections being resistant against ampicillin and vancomycin, respectively [1] .
Enterococci are frequently isolated from ascending urinary tract infections and from more severe infections like endocarditis, (neonatal) bloodstream infections, urosepsis and intra-abdominal sepsis [1, 4] . Surprisingly little is known about either bacterial virulence factors or host defense mechanisms operative in enterococcal infections. The immediate host defense after recognition of the microorganism consists of the opsonic bactericidal action of complement as well as phagocytosis by macrophages and/or neutrophils [5] . Previously, we investigated the involvement of several components of the innate immune response during E. faecium infection. We found Toll-like receptor 2, signaling via Myeloid Differentiation protein 88 [6] , neutrophils [7] and macrophages [8] contributing importantly to the initial host defense against E. faecium infection. In this study we investigated the role of the complement system. Previous in vitro studies demonstrated that complement proteins are of primary importance in neutrophil-mediated killing of E. faecalis and E. faecium and therefore were postulated to be essential in mounting an effi cient immune response [9, 10] . No studies, however, have subsequently been performed to investigate the role of the complement system in host defense against E. faecium infections in vivo.
To investigate the role of the complement system in vivo, we used a non-lethal mouse model of systemic E. faecium infection, caused by induction of E. faecium peritonitis [6] . Cobra Venom Factor (CVF) was used to deplete mice of complement; CVF forms a C3 convertase that rapidly and uncontrollable cleaves C3, resulting in hyperactivation of the complement cascade, thereby degrading the complement components, resulting 86 Chapter 5 in nearly complete depletion of complement activity [11, 12] . In additional experiments, C3-gene defi cient mice were used, which are completely defi cient in the late steps of complement activation regardless of the route used to initiate the complement pathway [13] .
Materials and Methods

Mice
Specifi c pathogen-free 10-wk-old female wildtype (WT) C57BL/6 mice were purchased from Harlan Sprague-Dawley (Horst, The Netherlands). Age-and gender-matched 
Depletion of complement by Cobra Venom Factor
To deplete mice of complement, 4 units of CVF (Quidel, Clindia Benelux, Leusden, The Netherlands) was injected intraperitoneally; control mice were intraperitoneally injected with saline. To evaluate the effi ciency and additional effects of CVF injection, 5 sex-and age-matched mice were injected with CVF or saline and sacrifi ced 16 hours thereafter, e.g. at the moment experimental mice were subjected to E. faecium peritonitis (see below). In these control mice C3 levels were measured in plasma and peritoneal fl uid, cell counts and -differentials were performed and baseline cytokine levels were measured according to methods described below. From our own (unpublished) experience and available literature [12] it was known that mice would have severely reduced levels of complement at least up till 3 days after CVF injection (<90% of normal values).
Bacterial strain
VRE strain, E155, was used in all experiments. This clinical isolate from the Cook County Hospital, Chicago, IL, belongs to a genetic subpopulation of hospital-associated E. faecium that is responsible for the worldwide emergence of nosocomial multiresistant E. faecium, characterized by high-level quinolone and ampicillin resistance, a pathogenicity 87 Complement in E. faecium peritonitis island, containing the variant esp gene, and the presence of fi ve cell surface protein genes [14, 15] . For all experiments the bacteria were grown overnight on sheep blood agar (BA) plates and then grown for approximately 3.5 hours in Todd-Hewitt (TH) broth (Difco, Detroit, MI) to midlogarithmic phase at 37˚C, while shaking.
Induction of peritonitis
Peritonitis was induced as described previously [6] . E. faecium was cultured as described above and washed twice in sterile saline to clear the bacteria of medium. Bacteria were then resuspended in sterile isotonic saline and mice were injected intraperitoneally with approximately 10 8 colony-forming units (CFU) of E. faecium in 200 μl saline. The inoculum was plated immediately after inoculation on BA plates to determine viable counts.
Peritonitis was induced 16 hours after CVF or saline injection. Additional peritonitis experiments were performed with C3 KO mice.
Collection of samples
For comparison of bacterial outgrowth and to examine host responses in the experimental groups, mice treated with either CVF or saline were killed at 6, 24 or 48 hours after infection. In the experiments comparing C3 KO and WT mice, animals were killed after 6 or 24 hours. Mice were anesthetized by inhalation of isofl urane (Abbot, Laboratories
Ltd., Kent, UK)/ 02 (2%/ 2 liter) and a peritoneal lavage was performed with 5 ml sterile phosphate-buffered-saline (PBS) using a 18-gauge needle; the peritoneal lavage fl uid (PLF) was collected in sterile polypropylene tubes (Plastipack; Beckton-Dickinson, Mountain
View, CA). After collection of PLF, blood was drawn by cardiac puncture, with a sterile syringe, transferred to heparin-gel vacutainer tubes and immediately placed on ice. Next, the abdomen and thorax were opened and the liver and lungs were harvested.
Determination of bacterial outgrowth
The number of E. faecium CFU was determined in PLF, blood, liver and lung homogenates.
Organs were weighed and homogenized at 4°C in 4 volumes of sterile saline using a tissue homogenizer (Biospect Products, Bartlesville, UK). Next, serial 10-fold dilutions were made of each sample in sterile saline and 50 μl of each dilution was plated onto blood agar plates. The plates were incubated at 37°C under 5% CO 2 , and CFU were counted after 20 hours and corrected for the dilution factor.
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Cell counts and differentials
Erythrocytes were lysed with ice-cold isotonic NH 4 
Opsonophagocytosis and bacterial killing assay
The role of complement in phagocytosis by neutrophils and peritoneal macrophages and killing by macrophages of this strain of E. faecium was fi rst tested ex vivo. Heat killed (70˚C, 20 min) and FITC-labeled bacteria were fi rst incubated (15 minutes) in 20 % heparinplasma from mice treated with saline or CVF (e.g. C3 depleted plasma) 16 hours earlier.
To determine the neutrophil phagocytosis capacity, 50 μl of whole blood was incubated with the two groups of preincubated bacteria (1x10 7 CFU/ml), and incubated for 10, 60 or 120 minutes at 37˚C. Cells were suspended in Quenching solution, incubated in FACS lysis/fi x solution (Beckton-Dickinson, Mountain View, CA) and neutrophils were labeled using anti-Gr-1-PE (BD Pharmingen, San Diego, CA), using concentrations recommended by the manufacturer.
Phagocytosis and killing by peritoneal macrophages were evaluated in essence as described before [6] . Peritoneal macrophages were harvested and cell numbers were counted using a Coulter Counter. Then the cells were washed, and resuspended in RPMI 1640 at a fi nal concentration of 5x10 5 cells/ml and were allowed to adhere in 48-well microtiter plates (Greiner, Alphen a/d Rijn, The Netherlands) overnight. For the phagocytosis assay macrophages were incubated with the two groups of preincubated E. faecium (2.5x10 7 CFU/ml), for 10, 60, or 120 minutes. Phagocytosis was stopped by placing cells on ice, after which cells were washed in PBS and suspended in Quenching solution (Orpegen, Heidelberg, Germany). Neutrophils and macrophages were washed with icecold FACS buffer after which the degree of phagocytosis by neutrophils and macrophages was determined using the FACSCalibur (Becton Dickinson). For the bacterial killing assay by peritoneal macrophages, cells were treated as described above (n=5 per strain). E.
faecium was grown to midlog-phase, and 1x10 9 CFU/ml was incubated in 20% plasma from CVF or saline treated mice, for 15 minutes. Then bacteria were washed, added on top of the seeded macrophages at a multiplicity of infection of 50 and spun onto cells at 2000 rpm for 5 min, after which plates were placed at 37˚C for 10 minutes. Each well was and bacterial counts were enumerated after 20h. Bacterial killing was expressed as the percentage of killed bacteria in relation to T = 0.
Assays
C3 was detected by sandwich ELISA as described [7] . Macrophage infl ammatory protein 
Statistical analysis
All data are expressed as mean ± SEM. Differences between groups were analyzed with
Mann-Whitney U test or Kruskal-Wallis analysis with Dunn post test where appropriate.
These analyses were performed using GraphPad Prism version 4 (GraphPad Software, San Diego, CA). Values of p < 0.05 were considered statistically signifi cant.
Results
Complement improves phagocytosis of E. faecium by neutrophils and macrophages, but does not infl uence intracellular killing
We fi rst sought to obtain insight into the consequence of opsonisation by complement of E. faecium on subsequent phagocytosis and killing by macrophages and neutrophils ex vivo. For this, E. faecium was preincubated in plasma of saline or CVF treated mice. CVF treatment led to a systemic and peritoneal reduction of the C3 protein of ≥ 90 % (Fig.   1 ). E. faecium preincubated in normal (saline) plasma was phagocytosed more rapidly by neutrophils and primary peritoneal macrophages compared to E. faecium incubated in plasma depleted of complement by CVF (p < 0.001, Fig. 2A and B) . Once internalized, opsonisation by complement did not infl uence killing by macrophages (Fig. 2C) . 
Impaired clearance of E. faecium in complement depleted mice
To determine the importance of complement in host defense against E. faecium peritonitis, mice were fi rst depleted of complement by injecting CVF (or as a control saline). CVF treated mice remained C3 depleted during the entire experiment (data not shown). Sixteen hours after CVF or saline treatment, mice were subjected to E. faecium peritonitis and sacrifi ced 6, 24 or 48 hours thereafter. Complement depletion caused a severe delay in E. faecium clearance (Fig. 3) . Six hours after the start of the infection > 2 log higher numbers of E. faecium were cultured from PLF of CVF treated mice compared to saline controls (Fig. 3A) . Higher peritoneal bacterial loads resulted in higher systemic spread and 6 hours after the start of the infection 1 log more E. faecium CFU was cultured from blood ( Fig. 3B) , liver ( Fig. 3C ) and lungs (Fig. 3D) . Both CVF and saline treated mice were able to reduce peritoneal and systemic E. faecium burdens. At 24 and 48 hours after infection, peritoneal E. faecium numbers were comparable in both groups of mice, whereas the amount of E. faecium in CVF treated mice in blood, liver and lungs remained elevated compared to control mice during the entire experiment.
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Effect of complement depletion on the infl ammatory response
At the time of infection, leukocyte counts and differentials in PLF and blood were similar in CVF and saline treated mice (Fig. 4 and data not shown). Induction of E. faecium peritonitis was associated with a brisk infl ux of neutrophils to the primary site of infection.
Six hours after infection CVF and saline treated mice had attracted similar amounts of neutrophils into the peritoneal cavity (Fig. 4A) . As the amount of peritoneal E. faecium decreased neutrophil numbers in PLF declined, returning to near baseline values after 48 hours in both groups (Fig. 4A ). E. faecium peritonitis resulted in an initial decrease in the number of peritoneal macrophages, as measured 6 hours post infection (Fig. 4B) , confi rming our previous results [8] . Thereafter, macrophage numbers increased again,
showing modestly higher counts from 24 hours onward. Although after 24 hours CVF treated mice tended to have lower macrophage numbers in their PLF, the difference with saline mice was not statistically signifi cant. Complement depletion did not infl uence the alterations in peripheral blood neutrophil or monocyte counts either (data not shown).
During the infection no differences were found with regard to circulating neutrophils and monocytes (data not shown).
To further evaluate the infl ammatory response in complement defi cient and suffi cient mice, we measured the levels of the proinfl ammatory cytokines TNF-α and IL-6 and the anti-infl ammatory cytokine IL-10, as well as MCP-1, in PLF and blood and neutrophil attracting CXC chemokines LIX, KC and MIP-2 in PLF. At the time of infection, CVF and saline treated mice had low or undetectable cytokine and chemokine levels that were not different between groups (data not shown). CVF treated mice sacrifi ced 6 hours after the infection showed higher peritoneal TNF-α and IL-6 levels than saline controls, corresponding with the 2 log higher CFU in the peritoneal cavity (Table 1) . Peritoneal IL-10 and MCP-1 levels were comparable in both groups as were plasma cytokine levels. The concentrations of KC, MIP-2 and LIX were all higher in CVF treated mice. Cytokine levels measured at later time points were undetectable or low in CVF and saline treated mice,
and not different between groups (data not shown). 
Impaired clearance of E. faecium in C3 KO mice
CVF treatment did not render mice absolutely depleted of complement ( Fig. 1 ) and may have other (toxic) effects. Therefore, we wished to confi rm the data reported above by using C3 KO mice in the same model of E. faecium peritonitis. C3 KO mice are absolute defi cient of C3, as we confi rmed by ELISA (not shown) and has previously been described [13] .
Six hours after the start of the infection C3 KO mice had > 3 log more E. faecium CFU in their PLF as compared to WT mice (Fig. 5A) . In blood, liver and lung about 2 log more E. faecium was cultured from C3 KO mice (Fig. 5B-D) . Twenty-four hours after the infection C3 KO mice still had higher numbers of E. faecium in their PLF, blood and lungs compared to WT mice, yet they had been able to reduce the amount of bacteria, even to a similar extent as WT mice in liver. No differences were found in peritoneal and peripheral cell composition or cytokine profi les between uninfected WT and C3 KO mice (data not shown). During the infection no differences were found in the peritoneal and peripheral cell composition (Fig. 6 and data not shown).
Higher peritoneal and blood IL-6 levels and peritoneal MIP-2, KC, LIX and MCP-1 chemokines were measured in C3 KO mice 6 hours after the infection (Table 2) . TNF-α and IL-10 were not found different in either plasma or PLF. No differences were measured after 24 hours.
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Discussion
In this study, we demonstrate for the fi rst time the involvement of the complement system in host defense against E. faecium infection in vivo. E. faecium has emerged as an important pathogen worldwide causing severe nosocomial infections. Because of the growing resistance to almost all antibiotics used in the hospital setting, infections with this multidrug resistant pathogen are diffi cult to treat. To improve therapeutic options, a better understanding of the pathogenesis of these infections and the interaction with host defense systems is needed. Previous in vitro studies indicated an important role for complement proteins in opsonizing enterococci and subsequent phagocytosis by neutrophils [9, 10] . After confi rming that opsonisation by complement enhances neutrophil, and additionally, macrophage phagocytosis of our clinical E. faecium isolate,
we investigated the role of the complement system during E. faecium infection in vivo.
Both groups of complement defi cient mice (decomplemented by use of CVF injection and C3 KO mice) were severely hampered in clearing E. faecium peritonitis. Especially early in the infection, complement defi cient mice had 2-3 log higher numbers of E.
faecium cultured from the peritoneal fl uid, resulting in higher systemic dissemination and a severe delay in E. faecium clearance. Higher E. faecium burden was accompanied by higher peritoneal cytokine and chemokine levels and higher systemic IL-6 levels in C3 KO mice. Interestingly, complement defi ciency did not hamper cell recruitment to the primary site of infection during E. faecium peritonitis.
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The complement system is a key player in the systemic defense system as well as in the peritoneal cavity [16] ; it comprises one of the major groups of pattern recognition Previous in vitro studies demonstrated neutrophil-mediated bactericidal activity towards enterococci was ablated by inactivation of complement. C4-defi cient serum promoted neutrophil killing consistently, suggesting that complement mediated neutrophil activity may proceed by the alternative pathway of complement [9, 10] . Additional studies demonstrated enhanced killing of enterococci when specifi c antibodies were involved. Huebner et al. [23] found that enterococcal glucose-glycerol-teichoic acid capsular polysaccharides (LTA) are targeted by antibodies in rabbits, and that antienterococcal rabbit serum had a protective effect in mice infected with enterococci. In an opsonophagocytic killing assay, antisera raised against purifi ed polysaccharide from E. faecalis killed a variety of heterologous strains of E. faecalis, as well as E. faecium, including vancomycin-resistant strains. Interestingly, certain strains of E. faecium were found resistant to phagocytosis by neutrophils, probably caused by a carbohydratecontaining moiety expressed by these strains. Specifi c antibodies could overcome this resistance, most likely by promoting deposition of complement [24] [25] [26] . In addition, extracellular gelatinase (GelE) expressed by E. faecalis destroys complement in human serum, by hydrolyzing C3a and degeneration of C3b [30, 31] . Expression of GelE was also described in E. faecium [32] , besides the described expression of capsular polysaccharides, this may contribute to the resistance to phagocytosis as well. were demonstrated to more easily internalize the bacteria when these were previously opsonized by complement. This is of importance as peritoneal macrophages are the cells that fi rst encounter the bacteria when introduced in the normally sterile peritoneal cavity [16] . This strain was clearly not resistant to phagocytosis.
We then tested the infl uence of complement in vivo. By injection of CVF, mice remain decomplemented for up to 3 days [12] . Decomplementation by CVF resulted in 90% reduction of C3 levels. CVF treated mice were severely debilitated in clearing enterococci, which was especially apparent early after infection. Six hours after the start of the infection they had up to 3 log more E. faecium in their peritoneal cavity, compared to the saline injected control mice, with increased systemic dissemination. Despite this prolonged increased bacterial load, no mortality was seen and apparently bacteria were not able to multiply in vivo, as at later time points the bacterial numbers were reduced also in decomplemented mice. Although CVF treatment caused a severe reduction in systemic complement proteins, some C3 could still be measured, potentially still playing a role in the reduction of the bacteria. We then examined if an absolute defi ciency in C3, using C3 KO mice, would render the host even more hampered in enterococcal clearance.
Like in the CVF treated mice, these experiments resulted in higher loads at the 6 hours time point in C3 KO mice, compared to the WT control mice, and also a reduction in load later in the infection.
Both cleavage products C3a and C5a are known anaphylatoxins, playing a role in attracting leukocytes to the site of infl ammation [27] [28] [29] . Interestingly, we did not fi nd differences in the attraction of neutrophils or macrophages into the peritoneal cavity in either model of complement defi cient mice. As such, the increased numbers of E. faecium in the peritoneal cavity were not due to reduced peritoneal cellular recruitment. Apparently, in the absence of an intact complement system, multiple compensatory mechanisms exist for the recruitment of neutrophils into the PLF after E. faecium infection. In this respect it should be noted that the peritoneal levels of the neutrophil attracting CXC chemokines KC, MIP-2 and LIX were elevated in complement defi cient mice 6 hours post infection, likely caused by the markedly higher bacterial loads at this time point, providing a 99
Complement in E. faecium peritonitis more potent proinfl ammatory stimulus for chemokine release; these elevated local CXC chemokine concentrations possibly compensated for the absent complement attracting function.
Our data show the requirement of complement for the early containment of E. faecium infection, with increased dissemination and severely hampered clearance in the absence of complement, which strongly suggests that complement is pivotal in the early antibacterial response during E. faecium infection primarily by facilitating phagocytosis.
